[{"Assets_0_FY_USD":13870100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":143400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":143300000.0,"StockholdersEquityConverted_0_FY_USD":5957600000.0,"StockholdersEquity_0_FY_USD":5958100000.0,"RevenuesConverted_1_FY_USD":1331200000.0,"RevenuesConverted_4_FY_USD":5280600000.0,"NetIncomeLossConverted_1_FY_USD":-1359100000.0,"NetIncomeLossConverted_4_FY_USD":-4012800000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":654900000.0,"EarningsPerShareDiluted_1_FY_USD":-9.48,"EarningsPerShareDiluted_4_FY_USD":-28.01,"EarningsPerShareBasic_1_FY_USD":-9.48,"EarningsPerShareBasic_4_FY_USD":-28.01,"CommonStockSharesConverted_0_FY_shares":143400000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":0.58,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":143300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":143400000.0,"Ticker":"PRGO_2","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20170522"}]